Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

Background and Aim Remimazolam tosilate (RT) is a new short‐acting GABA(A) receptor agonist, having potential to be an effective option for procedural sedation. Here, we aimed to compare the efficacy and safety of RT with propofol in patients undergoing upper gastrointestinal endoscopy. Methods This...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of gastroenterology and hepatology Ročník 36; číslo 2; s. 474 - 481
Hlavní autori:	Chen, Shao‐Hui, Yuan, Tang‐Mi, Zhang, Jiao, Bai, Hua, Tian, Ming, Pan, Chu‐Xiong, Bao, Hong‐Guang, Jin, Xiao‐Ju, Ji, Fu‐Hai, Zhong, Tai‐Di, Wang, Qiang, Lv, Jian‐Rui, Wang, Sheng, Li, Yu‐Juan, Yu, Yong‐Hao, Luo, Ai‐Lin, Li, Xiang‐Kui, Min, Su, Li, Lin, Zou, Xiao‐Hua, Huang, Yu‐Guang
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Australia Wiley Subscription Services, Inc 01.02.2021
Predmet:	Adverse events Anesthesia benzodiazepine endoscopic sedation Endoscopy GABA (A) receptor agonist Hypotension Propofol remimazolam remimazolam tosilate Safety Success upper gastrointestinal endoscopy γ-Aminobutyric acid GABA (A) receptor agonist remimazolam remimazolam tosilate endoscopic sedation upper gastrointestinal endoscopy benzodiazepine
ISSN:	0815-9319, 1440-1746, 1440-1746
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!